Patents by Inventor Timothy E. Trigg

Timothy E. Trigg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Formulations for peptide release
    Patent number: 6211152
    Abstract: A pharmaceutical and/or veterinary formulation comprising deslorelin and an excipient, the formulation being characterised in that, in vitro, it releases deslorelin into phosphate buffered saline, as hereinbefore described, at 37° C. at a rate of about 2-80 &mgr;g/day for at least 200 days. The formulation may be used for prevention of reproductive function, particularly in dogs and cats, and for the treatment, particularly in humans, of prostate and breast cancer and other diseases and conditions where suppression of testosterone or estradiol levels is beneficial.
    Type: Grant
    Filed: February 17, 1999
    Date of Patent: April 3, 2001
    Assignee: Peptech Limited
    Inventors: John D. Walsh, Timothy E. Trigg
  • Formulation for peptide release
    Patent number: 5925619
    Abstract: A pharmaceutical or veterinary formulation comprising deslorelin and an excipient is provided which releases in vitro deslorelin into phosphate buffered saline at 370.degree. C. at a rate of about 2-80 .mu.g/day for at least 200 days. The formulation may be used for prevention of reproductive function, particularly in dogs and cats, and for the treatment particularly in humans, of prostate and breast cancer and other diseases and conditions where suppression of testosterone or estradiol levels is beneficial.
    Type: Grant
    Filed: December 19, 1997
    Date of Patent: July 20, 1999
    Assignee: Peptech Limited
    Inventors: John D. Walsh, Timothy E. Trigg
  • Biocompatible implant for the timing of ovulation in mares
    Patent number: 5545408
    Abstract: The disclosed invention relates to a method for controlling the timing of the ovulation of mares using an LHRH agonist, and to a biocompatible implant for use in such a method.
    Type: Grant
    Filed: June 15, 1994
    Date of Patent: August 13, 1996
    Assignee: Peptide Technology Limited
    Inventors: Timothy E. Trigg, Edward L. Souires, Wolfgang Jochle